Your browser doesn't support javascript.
loading
Outcomes of refractory or relapsed Hodgkin lymphoma patients with post-autologous stem cell transplantation brentuximab vedotin maintenance: a French multicenter observational cohort study.
Marouf, Amira; Cottereau, Anne Segolene; Kanoun, Salim; Deschamps, Paul; Meignan, Michel; Franchi, Patricia; Sibon, David; Antoine, Clara; Gastinne, Thomas; Borel, Cecile; Hammoud, Mohammad; Sicard, Guillaume; Gille, Romane; Cavalieri, Doriane; Stamatoullas, Aspasia; Filliatre-Clement, Lauriane; Lazarovici, Julien; Chauchet, Adrien; Fornecker, Luc-Matthieu; Amorin, Sandy; Rocquet, Mathieu; Raus, Nicole; Burroni, Barbara; Rubio, Marie Therese; Bouscary, Didier; Quittet, Philippe; Casasnovas, Rene Olivier; Brice, Pauline; Ghesquieres, Herve; Tamburini, Jérôme; Deau, Benedicte.
Afiliación
  • Marouf A; Department of Hematology, Hôpital Cochin, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France; Université de Paris, France; INSERM UMR 1163, Institut Imagine, Paris.
  • Cottereau AS; Université de Paris, France; Department of Nuclear Medicine, Cochin Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris.
  • Kanoun S; Cancer Research Center of Toulouse (CRCT), Team 9, INSERM UMR 1037, Toulouse.
  • Deschamps P; Department of Hematology, Hôpital Cochin, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France; Université de Paris.
  • Meignan M; Lymphoma Academic Research Organization (LYSARC) Lymphoma Study Association Imaging, Hôpital Henri Mondor, Créteil, France; Paris Est University, Créteil.
  • Franchi P; Department of Hematology, Hôpital Cochin, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France; Université de Paris.
  • Sibon D; Hematology Department and INSERM U1151, Institut Necker Enfants Malades, Necker University Hospital, AP-HP, Paris.
  • Antoine C; Lymphoma Academic Research Organization (LYSARC) Lymphoma Study Association Imaging, Hôpital Henri Mondor, Créteil.
  • Gastinne T; Department of Hematology, Nantes University Hospital, Nantes.
  • Borel C; Department of Hematology, Institut universitaire du cancer Toulouse- Oncopole, Toulouse.
  • Hammoud M; Lymphoid Malignancies Unit, Hôpital Henri Mondor, Créteil.
  • Sicard G; Department of Haematology, Aix-Marseille University, Marseille.
  • Gille R; Department of Medical Oncology, Centre Léon Bérard, Lyon.
  • Cavalieri D; Department of Haematology, Centre Hospitalier Universitaire Estaing, Clermont-Ferrand.
  • Stamatoullas A; Department of Hematology, Centre Henri Becquerel, Rouen.
  • Filliatre-Clement L; Department of Hematology, Clinique Louis Pasteur, Nancy.
  • Lazarovici J; Department of Hematology, Institut Gustave-Roussy, Villejuif.
  • Chauchet A; Department of Hematology, CHU Besançon, Besançon.
  • Fornecker LM; Strasbourg University Hospital, Strasbourg, France; INSERM S-1113, Strasbourg, France; Strasbourg University, Faculty of medicine, Strasbourg.
  • Amorin S; Department of Hematology, Hôpital Saint Vincent de Paul, Lille.
  • Rocquet M; Department of Hematology, Hôpital Cochin, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris.
  • Raus N; Department of Hematology, Hôpital Lyon Sud, Pierre-Bénite, France; Société francophone de greffe de moelle et de thérapie cellulaire.
  • Burroni B; Service de pathologie, Hôpital Cochin, APHP, France; Centre de recherche des Cordeliers, Sorbonne University, INSERM, Paris University.
  • Rubio MT; Société francophone de greffe de moelle et de thérapie cellulaire, France; Department of Hematology, CHRU Nancy, Hôpital Brabois; CNRS UMR 7365, Équipe 6, Biopôle de L'Université de Lorraine, Vandoeuvre-les-Nancy.
  • Bouscary D; Department of Hematology, Hôpital Cochin, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France; Université de Paris, France; Institut Cochin, INSERM U1016, Paris.
  • Quittet P; Department of Hematology, University of Montpellier, Montpellier.
  • Casasnovas RO; Department of Hematology, Dijon University Hospital, Dijon, France; INSERM UMR 1231 CHU Dijon.
  • Brice P; Department of Hematology, CHU Paris-GH St-Louis Lariboisière F-Widal - Hôpital Saint-Louis, Paris.
  • Ghesquieres H; Department of Hematology, Centre Hospitalier Lyon Sud, Pierre-Bénite.
  • Tamburini J; Department of Hematology, Hôpital Cochin, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France; Université de Paris, France; Institut Cochin, INSERM U1016, Paris, France; Translational Research Centre in Onco-hematology, Faculty of Medicine, University of Geneva, 1211, Geneva 4.
  • Deau B; Department of Hematology, Hôpital Cochin, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France; Université de Paris. benedicte.deau-fischer@aphp.fr.
Haematologica ; 107(7): 1681-1686, 2022 07 01.
Article en En | MEDLINE | ID: mdl-34965701
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Inmunoconjugados / Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies Límite: Humans Idioma: En Revista: Haematologica Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Inmunoconjugados / Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies Límite: Humans Idioma: En Revista: Haematologica Año: 2022 Tipo del documento: Article